OmniAb Investor Presentation Deck
August 2023, 35 slides
  1. OmniAb
  2. Related Decks
  3. Investor Presentation Decks
august | OmniAb
disclaimer | OmniAb
our business leveraging our proprietary discovery technology platform poised for growth to meet a global industry need | OmniAb
mission our mission is to enable the rapid development of innovative therapeutics by pushing the frontiers of drug discovery technologies | OmniAb
antibodies and industry demand | OmniAb
growth of partner programs | OmniAb
performance indicators | OmniAb
select partners | OmniAb
performance indicators | OmniAb
and recent updates | OmniAb
the platform create screen deliver | OmniAb
the technology offering create screen deliver | OmniAb
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
the platform antibody generation technologies serif | OmniAb
rodent platforms | OmniAb
chicken platforms powered by evolution | OmniAb
create novel binding domains | OmniAb
common light chain platforms for antibodies i | OmniAb
diverse formats and modalities of preclinical and clinical molecules | OmniAb
antibody repertoires | OmniAb
screening platforms | OmniAb
the platform | OmniAb
ion channels and transporters | OmniAb
ion channels and transporters | OmniAb
intellectual property advantage all | OmniAb
business model license partnerships designed to include access fees potential collaboration service revenue milestones royalties on commercial sales | OmniAb
illustrative antibody deal structure profile a profile | OmniAb
financial results | OmniAb
balance sheet june | OmniAb
quarterly results | OmniAb
and financial results | OmniAb
share information as of | OmniAb
our key areas of focus going forward as | OmniAb
for more information please visit | OmniAb
approved under regulatory review and clinical stage partner pipeline | OmniAb
See More
OmniAb
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Royalty
Antibody discovery
Recent decks by OmniAb
Results
August 2023
Results
May 2023
Investor Presentation
May 2023
Results
March 2023
See all presentations by OmniAb (8 decks)
Related decks
AbCellera
Results
November 2022
AbCellera
Investor Presentation
July 2022
Evotec
Investor Presentation
July 2022
AbCellera
Results
February 2023
Theravance Biopharma
Results
February 2023
AbCellera
Investor Conference
September 2021
Alkermes
Results
February 2023
Absci
Investor Presentation
May 2022
Recent decks by OmniAb
See all presentations (8 decks)
Results
August 2023
Results
May 2023
Investor Presentation
May 2023
Results
March 2023
AbCellera
Results
November 2022
AbCellera
Investor Presentation
July 2022
Evotec
Investor Presentation
July 2022
AbCellera
Results
February 2023
Theravance Biopharma
Results
February 2023
AbCellera
Investor Conference
September 2021
Alkermes
Results
February 2023
Absci
Investor Presentation
May 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io